Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""NECROSIS"" wg kryterium: Temat


Tytuł :
Microglia Tweak Retinogeniculate Pathways during Visual Circuit Refinement.
Autorzy :
Keck T; Department of Neuroscience, Physiology and Pharmacology, University College London, 21 University St., London WC1E 6DE, UK. Electronic address: .
Pokaż więcej
Źródło :
Neuron [Neuron] 2020 Nov 11; Vol. 108 (3), pp. 397-399.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Microglia*
Tumor Necrosis Factors*
Receptors, Tumor Necrosis Factor ; TWEAK Receptor/genetics
Czasopismo naukowe
Tytuł :
Editorial: crystal gazing with magnetic resonance enterography to predict the response to TNF-alpha inhibitors in Crohn's disease.
Autorzy :
Zulfiqar M; Department of Radiology, Mallinckrodt Institute of Radiology, Washington University in Saint Louis, St. Louis, MO, USA.
Deepak P; Division of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis, St. Louis, MO, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Nov; Vol. 52 (9), pp. 1531-1532.
Typ publikacji :
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Crohn Disease*/diagnostic imaging
Crohn Disease*/drug therapy
Tumor Necrosis Factor-alpha*
Humans ; Magnetic Resonance Imaging ; Magnetic Resonance Spectroscopy ; Tumor Necrosis Factor Inhibitors
Raport
Tytuł :
Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners.
Autorzy :
Li X; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Zhang M; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Huang X; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Liang W; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Li G; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Lu X; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Li Y; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Pan H; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Shi L; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Zhu H; Department of Cell Biology, Harvard Medical School, 240 Longwood Ave., Boston, MA, 02115, USA.
Qian L; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China.
Shan B; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China. .
Yuan J; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Rd, PuDong District, 201203, Shanghai, China. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2020 Dec 11; Vol. 11 (1), pp. 6364. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Ubiquitination*
Receptor-Interacting Protein Serine-Threonine Kinases/*genetics
Receptor-Interacting Protein Serine-Threonine Kinases/*metabolism
Receptors, Tumor Necrosis Factor, Type I/*genetics
Receptors, Tumor Necrosis Factor, Type I/*metabolism
Signal Transduction/*physiology
Animals ; Apoptosis ; HEK293 Cells ; Humans ; Inflammation/metabolism ; Inflammation/pathology ; Mice ; Mice, Knockout ; Mutation ; Necroptosis/physiology ; Phosphorylation ; Splenomegaly/pathology ; Transcriptome ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł :
Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment.
Autorzy :
Tsai TF; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, 7 Zhong-Shan South Road, Zhongzheng District, Taipei, 10002, Taiwan.
Pokaż więcej
Źródło :
The British journal of dermatology [Br J Dermatol] 2020 Jul; Vol. 183 (1), pp. 7-8. Date of Electronic Publication: 2020 Feb 03.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Psoriasis*/drug therapy
Tumor Necrosis Factor-alpha*
Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Humans ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
PREDICTIVE FACTORS FOR LOSS OF RESPONSE TO ANTI-TNF IN CROHN'S DISEASE.
Autorzy :
Santos BRMD; Department of Surgery, Regional Hospital Rosa Pedrossian, Campo Grande, MS, Brazil.
Santos CHMD; Department of Surgery, Regional Hospital Rosa Pedrossian, Campo Grande, MS, Brazil.; Medicine, Anhanguera-Uniderp University, Campo Grande, MS, Brazil.
Santos VRMD; Department of Surgery, Regional Hospital Rosa Pedrossian, Campo Grande, MS, Brazil.
Torrez CYG; Department of Surgery, Regional Hospital Rosa Pedrossian, Campo Grande, MS, Brazil.
Palomares-Junior D; Department of Surgery, Regional Hospital Rosa Pedrossian, Campo Grande, MS, Brazil.
Pokaż więcej
Źródło :
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery [Arq Bras Cir Dig] 2020 Nov 20; Vol. 33 (2), pp. e1522. Date of Electronic Publication: 2020 Nov 20 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Drug Tolerance*
Crohn Disease/*drug therapy
Tumor Necrosis Factor Inhibitors/*therapeutic use
Adolescent ; Adult ; Crohn Disease/surgery ; Female ; Humans ; Infliximab/therapeutic use ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Tumor Necrosis Factor-alpha ; Young Adult
Czasopismo naukowe
Tytuł :
HOW TO TREAT PATIENTS AFTER SERIOUS ADVERSE EFFECTS CAUSED BY TNF INHIBITORS?
Autorzy :
Sršen S; 1Department of Pediatrics, Split University Hospital Centre, University of Split School of Medicine, Split, Croatia; 2Department of Pediatrics, Division of Pediatric Rheumatology and Immunology, Zagreb University Hospital Centre, University of Zagreb School of Medicine, Zagreb, Croatia.
Marušić E; 1Department of Pediatrics, Split University Hospital Centre, University of Split School of Medicine, Split, Croatia; 2Department of Pediatrics, Division of Pediatric Rheumatology and Immunology, Zagreb University Hospital Centre, University of Zagreb School of Medicine, Zagreb, Croatia.
Metličić V; 1Department of Pediatrics, Split University Hospital Centre, University of Split School of Medicine, Split, Croatia; 2Department of Pediatrics, Division of Pediatric Rheumatology and Immunology, Zagreb University Hospital Centre, University of Zagreb School of Medicine, Zagreb, Croatia.
Stričević L; 1Department of Pediatrics, Split University Hospital Centre, University of Split School of Medicine, Split, Croatia; 2Department of Pediatrics, Division of Pediatric Rheumatology and Immunology, Zagreb University Hospital Centre, University of Zagreb School of Medicine, Zagreb, Croatia.
Frković M; 1Department of Pediatrics, Split University Hospital Centre, University of Split School of Medicine, Split, Croatia; 2Department of Pediatrics, Division of Pediatric Rheumatology and Immunology, Zagreb University Hospital Centre, University of Zagreb School of Medicine, Zagreb, Croatia.
Jelušić M; 1Department of Pediatrics, Split University Hospital Centre, University of Split School of Medicine, Split, Croatia; 2Department of Pediatrics, Division of Pediatric Rheumatology and Immunology, Zagreb University Hospital Centre, University of Zagreb School of Medicine, Zagreb, Croatia.
Pokaż więcej
Źródło :
Acta clinica Croatica [Acta Clin Croat] 2020 Mar; Vol. 59 (1), pp. 161-165.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Peripheral Nervous System Diseases*
Tumor Necrosis Factor Inhibitors*/adverse effects
Adalimumab/adverse effects ; Child ; Child, Preschool ; Female ; Humans ; Male ; Retrospective Studies ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathway.
Autorzy :
Zhou J; Graduate School, Tianjin Medical University, Tianjin, 300070, People's Republic of China.; Department of Neurosurgery, Affiliated Hospital of Jining Medical University, & Shandong Provincial Key Laboratory of Stem Cells and Neuro-oncology, Jining, Shandong, 272029, People's Republic of China.
Li G; Department of Neurosurgery, Affiliated Hospital of Jining Medical University, & Shandong Provincial Key Laboratory of Stem Cells and Neuro-oncology, Jining, Shandong, 272029, People's Republic of China.
Han G; Department of Neurosurgery, Affiliated Hospital of Jining Medical University, & Shandong Provincial Key Laboratory of Stem Cells and Neuro-oncology, Jining, Shandong, 272029, People's Republic of China.
Feng S; Department of Neurosurgery, Affiliated Hospital of Jining Medical University, & Shandong Provincial Key Laboratory of Stem Cells and Neuro-oncology, Jining, Shandong, 272029, People's Republic of China.
Liu Y; Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Chen J; Department of Neurosurgery, Affiliated Hospital of Jining Medical University, & Shandong Provincial Key Laboratory of Stem Cells and Neuro-oncology, Jining, Shandong, 272029, People's Republic of China.; Clinical Medical College, Jining Medical University, Jining, Shandong, 272029, People's Republic of China.
Liu C; Department of Neurosurgery, Affiliated Hospital of Jining Medical University, & Shandong Provincial Key Laboratory of Stem Cells and Neuro-oncology, Jining, Shandong, 272029, People's Republic of China.; Clinical Medical College, Jining Medical University, Jining, Shandong, 272029, People's Republic of China.
Zhao L; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Jin F; Department of Neurosurgery, Affiliated Hospital of Jining Medical University, & Shandong Provincial Key Laboratory of Stem Cells and Neuro-oncology, Jining, Shandong, 272029, People's Republic of China. .
Pokaż więcej
Źródło :
Investigational new drugs [Invest New Drugs] 2020 Feb; Vol. 38 (1), pp. 50-59. Date of Electronic Publication: 2019 Mar 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Necroptosis*
Necrosis*
Emodin/*pharmacology
Glioma/*pathology
Nuclear Pore Complex Proteins/*metabolism
RNA-Binding Proteins/*metabolism
Receptor-Interacting Protein Serine-Threonine Kinases/*metabolism
Tumor Necrosis Factor-alpha/*metabolism
Animals ; Cell Cycle ; Cell Proliferation ; Female ; Glioma/drug therapy ; Glioma/metabolism ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Nuclear Pore Complex Proteins/genetics ; Protein Kinase Inhibitors/pharmacology ; RNA-Binding Proteins/genetics ; Reactive Oxygen Species/metabolism ; Receptor-Interacting Protein Serine-Threonine Kinases/genetics ; Signal Transduction ; Tumor Cells, Cultured ; Tumor Necrosis Factor-alpha/genetics ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX.
Autorzy :
Ko KP; Department of Life Sciences, Korea University, Seoul, 02841, Korea.
Jeong SI; Department of Life Sciences, Korea University, Seoul, 02841, Korea.
Lim JS; Department of Life Sciences, Korea University, Seoul, 02841, Korea.
Lee KW; Department of Life Sciences, Korea University, Seoul, 02841, Korea.
Lee MG; Department of Life Sciences, Korea University, Seoul, 02841, Korea.
Chi SG; Department of Life Sciences, Korea University, Seoul, 02841, Korea. .
Pokaż więcej
Źródło :
Oncogene [Oncogene] 2020 Aug; Vol. 39 (34), pp. 5675-5689. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Adaptor Proteins, Signal Transducing/*genetics
Apoptosis Regulatory Proteins/*genetics
Receptors, Tumor Necrosis Factor, Type I/*genetics
Repressor Proteins/*genetics
Ubiquitin-Protein Ligases/*genetics
bcl-2-Associated X Protein/*genetics
Adaptor Proteins, Signal Transducing/metabolism ; Animals ; Apoptosis/genetics ; Apoptosis Regulatory Proteins/metabolism ; Cell Line, Tumor ; HCT116 Cells ; HeLa Cells ; Humans ; Mice ; NF-kappa B/metabolism ; RNA Interference ; Receptors, Tumor Necrosis Factor, Type I/metabolism ; Repressor Proteins/metabolism ; Signal Transduction/genetics ; Survival Analysis ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/metabolism ; Ubiquitin-Protein Ligases/metabolism ; Xenograft Model Antitumor Assays/methods ; bcl-2-Associated X Protein/metabolism
Czasopismo naukowe
Tytuł :
[Cost of illness in axial spondylarthritis for patients with and without tumor necrosis factor inhibitor treatment: results of a routine data analysis].
Autorzy :
Redeker I; Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité - Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland. .; Programmbereich Epidemiologie, Deutsches Rheuma-Forschungszentrum, Charitéplatz 1, 10117, Berlin, Deutschland. .
Callhoff J; Programmbereich Epidemiologie, Deutsches Rheuma-Forschungszentrum, Charitéplatz 1, 10117, Berlin, Deutschland.
Hoffmann F; Department für Versorgungsforschung, Carl von Ossietzky Universität, Ammerländer Heerstr. 140, 26129, Oldenburg, Deutschland.
Saam J; BARMER Institut für Gesundheitssystemforschung, BARMER Gesetzliche Krankenversicherung, Lichtscheider Str. 89, 42285, Wuppertal, Deutschland.
Haibel H; Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité - Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland.
Sieper J; Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité - Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland.
Zink A; Programmbereich Epidemiologie, Deutsches Rheuma-Forschungszentrum, Charitéplatz 1, 10117, Berlin, Deutschland.; Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
Poddubnyy D; Medizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité - Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland.; Programmbereich Epidemiologie, Deutsches Rheuma-Forschungszentrum, Charitéplatz 1, 10117, Berlin, Deutschland.
Pokaż więcej
Transliterated Title :
Krankheitskosten bei axialer Spondyloarthritis für Patienten mit und ohne Tumor-Nekrose-Faktor-Inhibitor-Behandlung: Ergebnisse einer Routinedatenanalyse.
Źródło :
Zeitschrift fur Rheumatologie [Z Rheumatol] 2020 Feb; Vol. 79 (1), pp. 85-94.
Typ publikacji :
Journal Article
MeSH Terms :
Antirheumatic Agents*/therapeutic use
Health Care Costs*/statistics & numerical data
Spondylarthritis*/complications
Spondylarthritis*/drug therapy
Spondylarthritis*/economics
Tumor Necrosis Factor Inhibitors*/therapeutic use
Absenteeism ; Cost of Illness ; Data Analysis ; Germany ; Humans ; Treatment Outcome ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Tapering tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective study.
Autorzy :
Hacioglu A; Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey.
Hatemi G; Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey.
Esatoglu SN; Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey.
Hamuryudan V; Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey. .
Pokaż więcej
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2019 Nov-Dec; Vol. 37 Suppl 122 (6), pp. 8. Date of Electronic Publication: 2018 Apr 19.
Typ publikacji :
Letter
MeSH Terms :
Antirheumatic Agents*/administration & dosage
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Tumor Necrosis Factor Inhibitors*/administration & dosage
Tumor Necrosis Factor Inhibitors*/therapeutic use
Humans ; Remission Induction ; Retrospective Studies ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Opinia redakcyjna
Tytuł :
Successful treatment of tumor necrosis factor inhibitor-resistant cutaneous polyarteritis nodosa with tocilizumab.
Autorzy :
Inoue N; Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Shimizu M; Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Mizuta M; Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Yachie A; Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Pokaż więcej
Źródło :
Pediatrics international : official journal of the Japan Pediatric Society [Pediatr Int] 2020 Jun; Vol. 62 (6), pp. 753-755. Date of Electronic Publication: 2020 Jun 08.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized/*administration & dosage
Polyarteritis Nodosa/*drug therapy
Tumor Necrosis Factor-alpha/*metabolism
Child ; Drug Resistance ; Female ; Humans ; Interleukin-6/blood ; Polyarteritis Nodosa/diagnosis ; Positron-Emission Tomography ; Skin/pathology ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors/adverse effects ; Tumor Necrosis Factor Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł :
Anti-TNF Therapy Is Emerging as the Primary Treatment Modality in Pediatric Inflammatory Bowel Disease.
Autorzy :
Niklinska-Schirtz BJ; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Kugathasan S; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Pokaż więcej
Źródło :
Inflammatory bowel diseases [Inflamm Bowel Dis] 2020 Jan 01; Vol. 26 (1), pp. 139-140.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Inflammatory Bowel Diseases*
Tumor Necrosis Factor-alpha*
Canada ; Child ; Humans ; Infliximab ; Tumor Necrosis Factor Inhibitors
Opinia redakcyjna
Tytuł :
Can machine learning predict responses to TNF inhibitors?
Autorzy :
Nair N; Centre of Genetics & Genomics Versus Arthritis, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK. .
Wilson AG; University College Dublin Centre for Arthritis Research, Conway Institute, University College Dublin, Dublin, Ireland. .
Pokaż więcej
Źródło :
Nature reviews. Rheumatology [Nat Rev Rheumatol] 2019 Dec; Vol. 15 (12), pp. 702-704.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Arthritis, Rheumatoid*
Tumor Necrosis Factor Inhibitors*
Genetic Markers ; Humans ; Machine Learning ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Effects of myeloid cell-restricted TNF inhibitors in vitro and in vivo.
Autorzy :
Drutskaya MS; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Nosenko MA; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Gorshkova EA; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia.
Mokhonov VV; Blokhina Scientific Research Institute of Epidemiology and Microbiology of Nizhny Novgorod, Nizhny Novgorod, Russia.
Zvartsev RV; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Polinova AI; Lomonosov Moscow State University, Moscow, Russia.
Kruglov AA; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia.; German Rheumatism Research Center (DRFZ), a Leibniz Institute, Berlin, Germany.
Nedospasov SA; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia.; Institute of Cell Biology and Neurobiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Pokaż więcej
Źródło :
Journal of leukocyte biology [J Leukoc Biol] 2020 Jun; Vol. 107 (6), pp. 933-939. Date of Electronic Publication: 2020 Feb 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal/*pharmacology
Arthritis, Experimental/*therapy
CD11b Antigen/*antagonists & inhibitors
Calcium-Binding Proteins/*antagonists & inhibitors
Immunoglobulin Heavy Chains/*pharmacology
Myeloid Progenitor Cells/*drug effects
Receptors, G-Protein-Coupled/*antagonists & inhibitors
Tumor Necrosis Factor Inhibitors/*pharmacology
Animals ; Antirheumatic Agents/pharmacology ; Arthritis, Experimental/genetics ; Arthritis, Experimental/immunology ; Arthritis, Experimental/pathology ; CD11b Antigen/genetics ; CD11b Antigen/immunology ; Calcium-Binding Proteins/genetics ; Calcium-Binding Proteins/immunology ; Gene Expression ; Humans ; Infliximab/pharmacology ; Lipopolysaccharides/pharmacology ; Macrophages/drug effects ; Macrophages/immunology ; Mice ; Mice, Transgenic ; Myeloid Progenitor Cells/immunology ; Receptors, G-Protein-Coupled/genetics ; Receptors, G-Protein-Coupled/immunology ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/immunology
Czasopismo naukowe
Tytuł :
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden.
Autorzy :
Kopp TI; The Danish Multiple Sclerosis Registry, Department of Neurology, Rigshospitalet Glostrup, Glostrup, Denmark .; Center for Clinical Research and Prevention, Frederiksberg Hospital, Frederiksberg, Denmark.
Delcoigne B; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Arkema EV; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Jacobsen RK; Center for Clinical Research and Prevention, Frederiksberg Hospital, Frederiksberg, Denmark.
Magyari M; The Danish Multiple Sclerosis Registry, Department of Neurology, Rigshospitalet Glostrup, Glostrup, Denmark.; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, Kobenhavn, Denmark.
Ibfelt EH; Center for Clinical Research and Prevention, Frederiksberg Hospital, Frederiksberg, Denmark.; Clinical Epidemiology, Steno Diabetes Center Copenhagen, Gentofte, Denmark.
Locht H; Department of Rheumatology, Frederiksberg Hospital, Frederiksberg, Denmark.
Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, Kobenhavn, Denmark.
Cordtz RL; Center for Rheumatology and Spine Diseases - Gentofte, Rigshospitalet, Hellerup, Denmark.
Jensen DV; Center for Rheumatology and Spine Diseases - Gentofte, Rigshospitalet, Hellerup, Denmark.
Askling J; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Dreyer L; Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Pokaż więcej
Źródło :
Annals of the rheumatic diseases [Ann Rheum Dis] 2020 May; Vol. 79 (5), pp. 566-572. Date of Electronic Publication: 2020 Mar 11.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Registries*
Arthritis, Psoriatic/*drug therapy
Arthritis, Rheumatoid/*drug therapy
Demyelinating Diseases/*chemically induced
Spondylitis, Ankylosing/*drug therapy
Tumor Necrosis Factor Inhibitors/*adverse effects
Aged ; Arthritis, Psoriatic/diagnosis ; Arthritis, Rheumatoid/diagnosis ; Cohort Studies ; Demyelinating Diseases/epidemiology ; Denmark ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Nervous System Diseases/chemically induced ; Nervous System Diseases/epidemiology ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Risk Assessment ; Spondylitis, Ankylosing/diagnosis ; Sweden ; Tumor Necrosis Factor Inhibitors/administration & dosage ; Tumor Necrosis Factor-alpha/adverse effects ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.
Autorzy :
Bodio C; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy.
Grossi C; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy.
Pregnolato F; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy.
Favalli EG; Rheumatology Department, ASST Gaetano Pini-CTO, Milan, Italy.
Biggioggero M; Rheumatology Department, ASST Gaetano Pini-CTO, Milan, Italy.
Marchesoni A; Rheumatology Department, ASST Gaetano Pini-CTO, Milan, Italy.
Murgo A; Rheumatology Department, ASST Gaetano Pini-CTO, Milan, Italy.
Filippini M; Rheumatology and Clinical Immunology, ASST Spedali Civili di Brescia, Italy.
Migliorini P; Clinical Immunology, University of Pisa, Italy.
Caporali R; Department of Clinical Sciences and Community Health, University of Milan, Italy; IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
Pellerito R; Rehumatology, Ospedale Mauriziano, Torino, Italy.
Ciccia F; Rheumatology, University of Campania, Napoli, Italy.
Sarzi-Puttini P; Rheumatology Unit, ASST Fatebenefratelli-Sacco, University of Milan, Italy.
Perosa F; Department of Biomedical Science and Human Oncology, Rheumatologic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Bari, Italy.
Paolazzi G; UOC Reumatologia, Ospedale Santa Chiara, Trento, Italy.
Hollan I; Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway and Brigham and Women's Hospital, Cardiology Division, Boston, USA.
Bendtzen K; Institute for Inflammation Research IIR 7521, Rigshospitalet Natl. Univ. Hospital Copenhagen, Denmark.
Meroni PL; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy. Electronic address: .
Borghi MO; Istituto Auxologico Italiano, IRCCS, Experimental Laboratory of Immuno-rheumatology, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan, Italy.
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2020 May; Vol. 19 (5), pp. 102509. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Precision Medicine*
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Arthritis, Rheumatoid/*immunology
Tumor Necrosis Factor Inhibitors/*therapeutic use
Adalimumab/therapeutic use ; Biosimilar Pharmaceuticals/therapeutic use ; Cross-Sectional Studies ; Etanercept/therapeutic use ; Female ; Humans ; Infliximab/therapeutic use ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
An unexpected case of disseminated tuberculosis from tumour necrosis factor inhibition.
Autorzy :
Con D; Medical Registrar, Department of General Medicine, Eastern Health, VIC, Australia.
Gador-Whyte A; Infectious Diseases Advanced Trainee, Department of Infectious Diseases, Eastern Health, VIC, Australia.
MacGinley R; Nephrologist and General Physician, Department of General Medicine, Eastern Health, VIC, Australia; Eastern Health Clinical School Monash University, Melbourne, VIC, Australia.
Pokaż więcej
Źródło :
The New Zealand medical journal [N Z Med J] 2020 Jun 26; Vol. 133 (1517), pp. 126-128. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Infliximab/*adverse effects
Rheumatic Diseases/*drug therapy
Tuberculosis/*chemically induced
Tumor Necrosis Factor Inhibitors/*adverse effects
Adult ; Antirheumatic Agents/adverse effects ; Brain/diagnostic imaging ; Humans ; Magnetic Resonance Imaging ; Male ; Tuberculosis/diagnosis ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
TNF-α signaling: TACE inhibition to put out the burning heart.
Autorzy :
Dittrich GM; Department of Cardiovascular Physiology, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Heineke J; Department of Cardiovascular Physiology, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Pokaż więcej
Źródło :
PLoS biology [PLoS Biol] 2020 Dec 09; Vol. 18 (12), pp. e3001037. Date of Electronic Publication: 2020 Dec 09 (Print Publication: 2020).
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Receptors, Tumor Necrosis Factor, Type II*
Tumor Necrosis Factor-alpha*
ADAM17 Protein ; Cardiomegaly ; Humans ; Signal Transduction
Czasopismo naukowe
Tytuł :
Anti-TNF biosimilars in psoriasis: from scientific evidence to real-world experience.
Autorzy :
Barker J; St John's Institute of Dermatology King's College, London, UK.
Girolomoni G; Department of Medicine, University of Verona School of Medicine, Verona, Italy.
Egeberg A; Department of Dermatology and Allergy, Gentofte Hospital, Copenhagen, Denmark.
Goncalves J; Faculty of Pharmacy, iMed - Research Institute for Medicines, University of Lisbon, Lisbon, Portugal.
Pieper B; Biogen International GmbH, Baar, Switzerland.
Kang T; Samsung Bioepis Co., Ltd, Incheon, Republic of Korea.
Pokaż więcej
Źródło :
The Journal of dermatological treatment [J Dermatolog Treat] 2020 Dec; Vol. 31 (8), pp. 794-800. Date of Electronic Publication: 2019 May 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Biosimilar Pharmaceuticals/*therapeutic use
Psoriasis/*drug therapy
Tumor Necrosis Factor Inhibitors/*therapeutic use
Arthritis, Rheumatoid/drug therapy ; Biosimilar Pharmaceuticals/economics ; Biosimilar Pharmaceuticals/supply & distribution ; Cost Savings ; Drug Costs ; Health Services Accessibility/economics ; Humans ; Kaplan-Meier Estimate ; Tumor Necrosis Factor Inhibitors/economics ; Tumor Necrosis Factor Inhibitors/supply & distribution
Czasopismo naukowe
Tytuł :
Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2.
Autorzy :
Schwartz DA; Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Morotti D; Pathology Unit and Medical Genetics Laboratory, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Pokaż więcej
Źródło :
Viruses [Viruses] 2020 Nov 15; Vol. 12 (11). Date of Electronic Publication: 2020 Nov 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19/*transmission
Chorionic Villi/*pathology
Necrosis/*pathology
Pregnancy Complications, Infectious/*pathology
SARS-CoV-2/*pathogenicity
Trophoblasts/*pathology
COVID-19/mortality ; COVID-19/pathology ; COVID-19/virology ; Chorionic Villi/virology ; Female ; Fetal Mortality ; Fetus ; Humans ; Infectious Disease Transmission, Vertical/statistics & numerical data ; Necrosis/mortality ; Necrosis/virology ; Pregnancy ; Pregnancy Complications, Infectious/mortality ; Pregnancy Complications, Infectious/virology ; RNA, Viral/biosynthesis ; Risk Factors ; Severity of Illness Index ; Survival Analysis ; Trophoblasts/virology ; Virus Replication
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies